160 related articles for article (PubMed ID: 25374174)
1. miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator.
Zhu CL; Gao GS
Asian Pac J Cancer Prev; 2014; 15(20):8595-601. PubMed ID: 25374174
[TBL] [Abstract][Full Text] [Related]
2. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.
Cao Q; Lu K; Dai S; Hu Y; Fan W
Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949
[TBL] [Abstract][Full Text] [Related]
4. MiR-200a promotes cell invasion and migration of ovarian carcinoma by targeting PTEN.
Suo HB; Zhang KC; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4080-4089. PubMed ID: 30024595
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
[TBL] [Abstract][Full Text] [Related]
6. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer.
Ling S; Ruiqin M; Guohong Z; Ying W
Eur J Gynaecol Oncol; 2015; 36(4):463-8. PubMed ID: 26390704
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q; Guo R; Lin M; Zhou B; Wang Y
Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
[TBL] [Abstract][Full Text] [Related]
10. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis.
Gong L; Wang C; Gao Y; Wang J
Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550
[TBL] [Abstract][Full Text] [Related]
12. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
13. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
Li J; Liang SH; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
16. The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer.
Sun Q; Zou X; Zhang T; Shen J; Yin Y; Xiang J
Gynecol Oncol; 2014 Mar; 132(3):730-8. PubMed ID: 24503464
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs associated with increased AKT gene number in human lung carcinoma.
Goto A; Dobashi Y; Tsubochi H; Maeda D; Ooi A
Hum Pathol; 2016 Oct; 56():1-10. PubMed ID: 27189341
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.
Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H
Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]